Pharmascience and PHOENIX group sign partnership contract


Pharmascience and PHOENIX group are proud to announce the signature of a partnership agreement in Mannheim, Germany. 

One of the leading Canadian manufacturers of generic and branded drugs, Pharmascience, was founded by two pharmacists in 1983 and is active in over 60 countries. PHOENIX group is the biggest European Healthcare Provider covering 27 markets with pharmaceutical wholesale, healthcare logistics and more than 2,500 own pharmacies and more than 13,500 cooperation pharmacies.

 “We are happy to partner with one of the biggest European healthcare providers to expand our activities in the important European markets,”says Jean-Guy Goulet, Chief Operating Officer of Pharmascience. 

“This partnership opens new opportunities for both sides,” says Oliver Windholz, CEO PHOENIX group, “We are happy to work closely together to give European patients access to Pharmascience’s world-class branded and generic products.”

Founded by pharmacists Morris Goodman and Ted Wise in 1983, based in Québec, Canada, Pharmascience is a leading manufacturer of generic and branded drugs in Canada. With over 1,600 employees, Pharmascience is the largest pharmaceutical employer in the Canadian province Québec. The company has nearly 400 product families in 20 different dosage forms for over 2,000 products.

PHOENIX group, headquartered in Mannheim, Germany, is a leading healthcare provider in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 37,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.


Back to Stories